Medication adherence following pharmacogenomic testing in patients with major depressive disorder
{{output}}
Objective: Approximately 50% of patients with major depressive disorder (MDD) prematurely discontinue their antidepressant medication within 6 months, increasing risk of relapse. Pharmacogenomic (PGx) testing may improve medicati... ...
